Loading...
XSHE
300896
Market cap6.10bUSD
Dec 05, Last price  
142.97CNY
1D
1.82%
1Q
-25.08%
IPO
-24.79%
Name

Imeik Technology Development Co Ltd

Chart & Performance

D1W1MN
XSHE:300896 chart
P/E
22.01
P/S
14.24
EPS
6.49
Div Yield, %
2.27%
Shrs. gr., 5y
6.84%
Rev. gr., 5y
40.24%
Revenues
3.03b
+5.45%
75,124,088111,817,498140,732,063222,489,964321,011,015557,715,652709,290,1971,447,872,0011,938,838,3632,869,347,2313,025,668,449
Net income
1.96b
+5.33%
28,419,40417,652,01053,377,01582,193,507122,854,839305,519,840439,748,783957,979,5851,263,558,4151,858,475,3021,957,596,837
CFO
1.93b
-2.76%
27,949,80048,345,80054,997,80084,158,823135,496,573309,715,080425,677,596942,779,5081,193,935,2031,981,901,4091,927,174,523
Dividend
Apr 29, 20243.2522 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Imeik Technology Development Co.,Ltd focuses on the research and development, production, and sale of biomedical materials. The company offers medical beauty field products, including Moisten Angel, IFRESH, Yimei, Hearty, Bonita Bonita, and Tightly. It also offers skin care products, including moisturizing lotions, anti-wrinkle firming kinetic energy liquids, essence creams, hydrating firming masks, chitosan B5 repair sprays, and purifying and brightening kinetic liquids. The company was founded in 2004 and is based in Beijing, China.
IPO date
Sep 28, 2020
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT